Loading…
Affordable Care and Comprehensive Economic Support through Savings Act
Legislative Progress
Introduced
September 20, 2023
Latest Action
December 17, 2024
Primary Sponsor
W. Gregory SteubeRepublican(FL)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
94pct
454d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2025 · first_quarter · Health Issues
Referred to the Subcommittee on Health.
Referred to the Subcommittee on Health.
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions) H.R. 3433, Give Kids a Chance Act of 2024 (generally, no specific provisions) H.R. 7623, Telehealth Modernization Act of 2024 (generally, no specific provisions) S. 2780, Medication Affordability and Patent Integrity Act (generally, no specific provisions) S. 4583, Creating Hope Reauthorization Act of 2024 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Pharmacy
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions) H.R. 3433, Give Kids a Chance Act of 2024 (generally, no specific provisions) H.R. 7623, Telehealth Modernization Act of 2024 (generally, no specific provisions) S. 2780, Medication Affordability and Patent Integrity Act (generally, no specific provisions) S. 4583, Creating Hope Reauthorization Act of 2024 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medicare/Medicaid
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Defense
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Agriculture
Monitoring all agricultural issues; agriculture appropriations. HR 5608 and S. 4111 - CWD Research and Management Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Defense
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Copyright/Patent/Trademark
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Pharmacy
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medicare/Medicaid
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Pharmacy
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medicare/Medicaid
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Defense
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Copyright/Patent/Trademark
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Defense
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions) H.R. 3433, Give Kids a Chance Act of 2024 (generally, no specific provisions) H.R. 7623, Telehealth Modernization Act of 2024 (generally, no specific provisions) S. 2780, Medication Affordability and Patent Integrity Act (generally, no specific provisions) S. 4583, Creating Hope Reauthorization Act of 2024 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medicare/Medicaid
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Pharmacy
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act H.R. 3433, Give Kids a Chance Act of 2024 H.R. 7623, Telehealth Modernization Act of 2024 S. 2780, Medication Affordability and Patent Integrity Act S. 4583, Creating Hope Reauthorization Act of 2024
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Agriculture
Monitoring all agricultural issues; agriculture appropriations. HR 5608 and S. 4111 - CWD Research and Management Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
H.R. 6033: SPEAK Act - provisions related to the CBO score and language barriers in the telehealth sector. H.R. 5608: Affordable Care and Comprehensive Economic Support through Savings (ACCESS) Act - provisions related to expansion of HSA access. S. 1869: The SITE Act - provisions related to enacting site neutral payments. HR 1843: Telehealth Expansion Act of 2023 - provisions related to permanently exempting high deductible health plans from the requirement of a deductible for telehealth and other remote care services. HR 4507: Transparency in Coverage Act of 2023 - provisions related to promoting transparency in health coverage and reform pharmacy benefit management services with respect to group health plans, and for other purposes. HR 8089: Medicare and Medicaid Fraud Prevention Act of 2024 - provisions related to the requirement that state Medicaid programs check, as part of the provider enrollment and reenrollment process, whether providers are deceased through the Social Security Administration's Death Master File. Issues related to medicare and medicaid fraud prevention and Medicare EOB no later than 30 days. Issues related to increaseing direct primary care. Issues related to increasing telehealth access and availability. Issues related to removing the ban on physician owned hospitals. Issues related to decoupling HSAs from high deductible plans. Issues related to removing barriers for non-English speakers or those with disabilities on Federal health care forms. Issues related to ending the enhanced subsidies for the Affordable Care Act. Issues related to broadly enacting a personal option in health care (Personal Option legislation).
Client expense: $220,000 · Firm income: Not reported
2024 · second_quarter · Health Issues
H.R.485, Protecting Health Care for All Patients Act H.R.5378, Lowering Costs, More Transparency Act H.R.6283/S.1542, DRUG Act H.R.1385/S.1424, DOC Access Act H.R.5608, ACCESS Act H.R.5539/S.3131, ORPHAN Cures Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Defense
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Copyright/Patent/Trademark
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Pharmacy
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Medicare/Medicaid
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Medicare/Medicaid
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Defense
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Pharmacy
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Copyright/Patent/Trademark
The DRUG Act, H.R.6283/S.1542 (generally, no specific provisions) The DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions) The ACCESS Act, H.R.5608 (generally, no specific provisions) The ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Medicare/Medicaid
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Health Issues
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Pharmacy
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Copyright/Patent/Trademark
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Defense
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Copyright/Patent/Trademark
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Medicare/Medicaid
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Pharmacy
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Health Issues
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Defense
Issues related to pharmaceutical patents and healthcare programs; the DRUG Act, H.R.6283/S.1542 (generally, no specific provisions); the DOC Access Act, H.R.1385/S.1424 (generally, no specific provisions); the ACCESS Act, H.R.5608 (generally, no specific provisions); the ORPHAN Cures Act, H.R.5539/S.3131 (generally, no specific provisions)
Client expense: Not reported · Firm income: Not reported
2024 · second_quarter · Health Issues
H.R. 5608: Affordable Care and Comprehensive Economic Support through Savings (ACCESS) Act - provisions related to expansion of HSA access. H.R. 6033: SPEAK Act - provisions related to the CBO score and language barriers in the telehealth sector. H.R. 5568: CARE for Mom's Act - provisions related to maternal health and some rural maternity/maternal rural health services. H.R. 7863: To require the Secretary of Health and Human Services to issue guidance on furnishing behavioral health services via telehealth to individuals with limited English proficiency under Medicare program. - provisions related to language access barriers in the telehealth space tied to the Latino community. H.R. 977: Patient Access to Higher Quality Health Care Act of 2023 - provisions related to removing the ban on physician owned hospitals. S. 1869: Transparency Enhancement Act - provisions related to enacting site neutral payment reforms in Medicare. Issues related to advocating for site neutral payment reforms and ending enhanced ACA Subsidies. Issues related to removing the ban on physician owned hospitals to increase competition. Issues related to decoupling HSAs from high deductible insurance plans and increasing the contribution limit. Issues related to increasing DPC, HSAs, and site neutral payments Issues related to HSA expansion and decoupling from high deductible insurance plans as well as telehealth expansion. Issue issues related to expansion of telehealth and HSAs. Issues related to Increasing HSA access to all individuals and specifically for seniors. Issues related to HSA expansion and Direct Primary Care Expansion. Issues related to advocating for universal HSA access. Issues related to Health Care sunset ACA Subsidy enhancements Issues related to Personal Option Legislation. Issues related to removing barriers to direct primary care, increasing access to HSAs, enacting site neutral payment reforms, removing the ban on physician owned hospitals. Issues related to the upcoming fiscal cliff.
2024 · second_quarter · Agriculture
Monitoring all agricultural issues; agriculture appropriations. HR 5608 and S. 4111 - CWD Research and Management Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Agriculture
Monitoring all agricultural issues; agriculture appropriations. HR 5608 and S. 4111 - CWD Research and Management Act.
Client expense: Not reported · Firm income: $20,000
Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| TN |
| Kat Cammack | Republican | FL |
| Laurel M. Lee | Republican | FL |
| Nicholas A. Langworthy | Republican | NY |
| Richard McCormick | Republican | GA |
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Client expense: $260,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE